KR970064584A - 동결건조된 백신 성분을 함유하는 용기 - Google Patents

동결건조된 백신 성분을 함유하는 용기 Download PDF

Info

Publication number
KR970064584A
KR970064584A KR1019970007346A KR19970007346A KR970064584A KR 970064584 A KR970064584 A KR 970064584A KR 1019970007346 A KR1019970007346 A KR 1019970007346A KR 19970007346 A KR19970007346 A KR 19970007346A KR 970064584 A KR970064584 A KR 970064584A
Authority
KR
South Korea
Prior art keywords
vaccine
container according
component
container
lysate
Prior art date
Application number
KR1019970007346A
Other languages
English (en)
Other versions
KR100458370B1 (ko
Inventor
테오도루스 마리아 빌데르베크 안토니우스
알머 미델베크 한스
Original Assignee
에프. 지. 엠. 헤르만스; 이. 에이치. 리링크
악조 노벨 엔. 브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 지. 엠. 헤르만스; 이. 에이치. 리링크, 악조 노벨 엔. 브이. filed Critical 에프. 지. 엠. 헤르만스; 이. 에이치. 리링크
Publication of KR970064584A publication Critical patent/KR970064584A/ko
Application granted granted Critical
Publication of KR100458370B1 publication Critical patent/KR100458370B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Solid Materials (AREA)

Abstract

본 발명은 하나 이상의 동결건조된 백신 성분을 함유하는 백신 용기에 관한 것이다. 백신 성분(들)은 두 개 이상의 동결건조체(이들 동결건조체 중 하나 이상은 용해구(溶解球 : lyosphere)임) 내에 존재한다. 또한, 본 발명은 상기 백신 용기의 제조방법에 관한 것이다. 또한, 본 발명은 백신 용기를 포함하는 백신 팩에 관한 것이다.

Description

동결건조된 백신 성분을 함유하는 용기
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 하나 이상의 동결건조된 백신 성분을 함유하는 백신 용기로서, 상기 백신 성분(들)은 두 개 이상의 동결건조체 내에 존재하며, 상기 동결건조체 중 하나 이상은 용해구임을 특징으로 하는 백신 용기.
  2. 제1항에 있어서, 상기 동결건조체가 용해구임을 특징으로 하는 백신 용기.
  3. 제1항 또는 제2항에 있어서, 상기 하나 이상의 동결건조체가 하나의 단일 백신 성분을 포함하는 것을 특징으로 하는 백신 용기.
  4. 제1항 내지 제3항 중 어느 한 항에 있어서, 상기 동결건조체 각각이 하나의 단일 백신 성분을 포함하는 것을 특징으로 하는 백신 용기.
  5. 제1항 내지 제4항 중 어느 한 항에 있어서, 상기 백신 성분이 두 개 이상의 병원체로부터 유도된 것임을 특징으로 하는 백신 용기.
  6. 제1항 내지 제5항 중 어느 한 항에 있어서, 상기 용해구의 직경이 1 내지 10㎜임을 특징으로 하는 백신 용기.
  7. 제1항 내지 제6항 중 어느 한 항에 있어서, 상기 동결건조체 각각이 상기 용해구의 내용물을 표시하는 색으로 착색됨을 특징으로 하는 백신 용기.
  8. 제1항 내지 제7항 중 어느 한 항에 있어서, 상기 동결건조체 중 하나 이상이 강성 매트릭스를 포함함을 특징으로 하는 백신 용기.
  9. 제8항에 있어서, 상기 매트릭스가 백신 성분의 느린 방출을 가능하게 함을 특징으로 하는 백신 용기.
  10. 제1항 백신 용기를 제조하는 방법으로서, 하나 이상의 백신 성분을 포함하는 다른 동결건조체를 포함하는 용기에 하나 이상의 백신 성분을 포함하는 하나 이상의 용해구를 첨가하는 단계를 포함하는 것을 특징으로 하는 방법.
  11. 제2항에 따른 백신 용기를 제조하는 방법으로서, 용기에 하나 이상의 백신 성분을 포함하는 두 개 이상의 용해구를 첨가하는 단계를 포함하는 것을 특징으로 하는 방법.
  12. 제1항 내지 제9항의 백신 용기를 포함하는 백신 팩.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019970007346A 1996-03-07 1997-03-06 동결건조된백신성분을함유하는용기 KR100458370B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200621.9 1996-03-07
EP96200621 1996-03-07

Publications (2)

Publication Number Publication Date
KR970064584A true KR970064584A (ko) 1997-10-13
KR100458370B1 KR100458370B1 (ko) 2005-07-07

Family

ID=8223754

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970007346A KR100458370B1 (ko) 1996-03-07 1997-03-06 동결건조된백신성분을함유하는용기

Country Status (19)

Country Link
US (2) US5897852A (ko)
EP (1) EP0799613B1 (ko)
JP (1) JP4293643B2 (ko)
KR (1) KR100458370B1 (ko)
CN (1) CN1133423C (ko)
AT (1) ATE202925T1 (ko)
AU (1) AU704629B2 (ko)
CA (1) CA2198195C (ko)
DE (1) DE69705569T2 (ko)
DK (1) DK0799613T3 (ko)
EG (1) EG23992A (ko)
ES (1) ES2161412T3 (ko)
GR (1) GR3036725T3 (ko)
HU (1) HU220532B1 (ko)
IL (1) IL120202A (ko)
NZ (1) NZ314267A (ko)
PT (1) PT799613E (ko)
SA (1) SA97170715B1 (ko)
ZA (1) ZA971734B (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
AU779403B2 (en) * 1999-08-24 2005-01-20 Teva Pharmaceutical Industries Ltd. A vaccine composition and method of using the same
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
AUPR750501A0 (en) * 2001-09-05 2001-09-27 Gauci, Mark Products comprising quantum of bioparticles and method for production thereof
US6780581B2 (en) 2001-09-12 2004-08-24 Btf Pty Ltd Products comprising quantum of bioparticles and method for production thereof
US20140248273A1 (en) 2001-09-08 2014-09-04 Jos van Strijp Vaccine based on staphylococcal superantigen-like 3 protein (ssl3)
RU2006126051A (ru) * 2003-12-19 2008-01-27 Альк-Абелло А/С (Dk) Способы получения партии активного фармацевтического ингредиента, контейнер, содержащий криогранулы аллергенного продукта, и криогранула аллергенного продукта
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
TWI436789B (zh) * 2008-01-21 2014-05-11 Intervet Int Bv 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CA2716399C (en) 2008-03-05 2020-07-21 Pierre Chouvenc Process for stabilizing an adjuvant containing vaccine composition
EP2143440A1 (fr) 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
TW201043267A (en) * 2009-03-19 2010-12-16 Intervet Int Bv In situ constituting a vaccine for administration to a predetermined herd of animals
EP2658568A1 (en) 2010-12-29 2013-11-06 Intervet International B.V. Canine babesiosis vaccine antigen
WO2013066769A1 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Methods of preparing lyophilized spherical-shaped pellets of biological materials
US10617650B2 (en) * 2015-10-16 2020-04-14 Merck Sharp & Dohme Corp. Process for preparing formulations for gastrointestinal-targeted therapies
NL2018155B1 (en) 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
CN113862332A (zh) * 2021-09-17 2021-12-31 浙江大学 琼脂糖在制备生物大分子冻干保护剂中的应用
CN114159555A (zh) * 2021-12-08 2022-03-11 江西赛基生物技术有限公司 抗原蛋白冻干小球及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655838A (en) * 1969-03-20 1972-04-11 Organon Method of pelletizing analytical or immunological reagents
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
SE425461B (sv) * 1971-09-03 1982-10-04 Du Pont Sett att framstella en homogen, lyofiliserad produkt av blodserum eller blodplasma
US3857423A (en) * 1971-12-27 1974-12-31 W Ronca Topical medicament kit with interlocking components
US3893280A (en) * 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
US4351158A (en) * 1980-01-22 1982-09-28 American Home Products Corporation Method of producing multicomponent lyophilized product
US4295280A (en) * 1980-03-17 1981-10-20 American Home Products Corporation Method of obtaining a lyophilized product
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
IL86180A (en) 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines
AT390192B (de) * 1988-08-29 1990-03-26 Immuno Ag Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen
US5044091B1 (en) * 1989-04-18 1997-12-30 Sankyo Co Method of preparing a freeze-dried formulation of a drug
CA2030551C (en) * 1989-05-01 1998-08-25 Wayne Gombotz Process for producing small particles of biologically active molecules
IE64738B1 (en) 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
CA2051092C (en) * 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
JPH08509483A (ja) * 1993-04-28 1996-10-08 アクゾ・ノベル・エヌ・ベー ゴナドトロピンを含有するライオスフィア
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components

Also Published As

Publication number Publication date
HU9700556D0 (en) 1997-04-28
ATE202925T1 (de) 2001-07-15
NZ314267A (en) 1998-01-26
JPH1024090A (ja) 1998-01-27
ES2161412T3 (es) 2001-12-01
KR100458370B1 (ko) 2005-07-07
DK0799613T3 (da) 2001-10-22
EP0799613B1 (en) 2001-07-11
US5897852A (en) 1999-04-27
AU1514997A (en) 1997-09-11
ZA971734B (en) 1997-09-09
CN1133423C (zh) 2004-01-07
GR3036725T3 (en) 2001-12-31
HUP9700556A3 (en) 2000-04-28
DE69705569T2 (de) 2002-05-16
IL120202A0 (en) 1997-06-10
EP0799613A1 (en) 1997-10-08
PT799613E (pt) 2001-12-28
IL120202A (en) 2001-03-19
AU704629B2 (en) 1999-04-29
CA2198195C (en) 2005-10-25
CA2198195A1 (en) 1997-09-07
CN1163102A (zh) 1997-10-29
JP4293643B2 (ja) 2009-07-08
EG23992A (en) 2008-03-09
HUP9700556A2 (en) 1997-12-29
US6106836A (en) 2000-08-22
DE69705569D1 (de) 2001-08-16
HU220532B1 (hu) 2002-03-28
SA97170715B1 (ar) 2006-10-11
MX9701726A (es) 1998-03-31

Similar Documents

Publication Publication Date Title
KR970064584A (ko) 동결건조된 백신 성분을 함유하는 용기
GB2319836B (en) Microplates
RU94007635A (ru) Комбинированный препарат для контрацепции
BR0017112A (pt) Produto detergente
KR950007856A (ko) 경구 투여용 라파마이신 제형
HUP9900346A2 (hu) Avermektineket és depszipeptideket tartalmazó endoparazita ellenes hatású gyógyászati készítmények
BR9914343B1 (pt) compósito dental, e, processo de preparação de um compósito dental compreendendo uma composição polimerizada.
NZ316787A (en) Methods and compositions for the selective modification of nucleic acids
ES2131556T3 (es) Fibra aglutinable termicamente para telas no tejidas de alta resistencia.
ID27457A (id) Komposisi untuk pengobatan hiv dan infeksi virus lainnya
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
BR9502555A (pt) Composiçao que consiste de um dendrímero e de uma substancia ativa ocluida no dendrímero processo para a preparaçao de uma tal composiçao e processo para liberaçao de uma substancia ativa
PT1318791E (pt) Composicao farmaceutica semi-solida de isotretinoina
CA2338684A1 (en) Injectable propofol formulations
ATE91262T1 (de) Geblasene, einstueckige flasche und verfahren zur herstellung derselben.
BR0105802A (pt) Composição de tintura de oxidação das fibras queratìnicas compreendendo derivados de para-fenilenodiamina com grupo pirrolidinila, processo de tintura de oxidação das mesmas, dispositivos com vários compartimentos, ou "kit" de tintura com vários compartimentos e, produto colorido resultante da oxidação
DE69624364D1 (de) Abführmittel enthaltend lactitol und psyllium
GB0117783D0 (en) Illumination method illumination system and the components thereof, especially for illuminating hollow bodies such as signs inscriptions letters especially r
ES2096988T3 (es) Organopolisiloxanos que contienen grupos hidrofilos.
BR9908195A (pt) Derivado do grupo b das estreptograminas, processo para a preparação do mesmo, composições farmacêuticas, e, associações de derivados de estreptograminas.
BR9917242B1 (pt) processo para a polimerização de uma olefina e/ou uma olefina e pelo menos uma ou mais outra(s) olefina(s), e, processo para redução da carga eletrostática gerada na polimerização de uma olefina e/ou uma olefina e pelo menos uma ou mais outra(s) olefina(s).
PT633928E (pt) Microrganismos processo de preparacao e utilizacao
ES2098407T3 (es) Procedimiento para la obtencion de caprolactama mediante transposicion de beckmann de ciclohexanonoxima.
ES2183169T3 (es) Hidrogenofluorosulfonatos de base organica, su utilizacion para liberar las bases organicas de su fluorhidrato, su procedimiento de preparacion, composicion que los contiene.
BR9805110A (pt) Dispositivo para acoplamento ou separação de uma embreagem de arraste

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121030

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20131030

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20141030

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20150930

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20161028

Year of fee payment: 13

EXPY Expiration of term